OmniAb (OABI) Other Operating Expenses (2021 - 2026)
OmniAb (OABI) reported Other Operating Expenses of $46000.0 for Q1 2026, down 93.87% year-over-year from $750000.0 in Q1 2025, and up 129.3% quarter-over-quarter from -$157000.0 in Q4 2025.
OmniAb (OABI) Other Operating Expenses (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Other Operating Expenses data on file, last reported at $46000.0 in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $46000.0, down 93.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 million (down 41.78% YoY), and the FY2025 annual result was $2.5 million, up 7.78% from the prior year.
- Other Operating Expenses climbed to $46000.0 in Q1 2026 per OABI's latest filing, from -$157000.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $2.5 million in Q2 2024 and troughed at -$165000.0 in Q2 2022.
- A 5-year average of $315352.9 and a median of $34000.0 in 2025 frame the typical range for Other Operating Expenses.
- On a YoY basis, Other Operating Expenses climbed as much as 5589.7% in 2022 and fell as far as 7651.49% in 2022.
- A 5-year view of Other Operating Expenses shows it stood at $106000.0 in 2022, then plunged by 86.79% to $14000.0 in 2023, then soared by 192.86% to $41000.0 in 2024, then sank by 482.93% to -$157000.0 in 2025, then soared by 129.3% to $46000.0 in 2026.
- Business Quant data shows OABI's Other Operating Expenses at $46000.0 in Q1 2026, -$157000.0 in Q4 2025, and $34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | -157,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 750,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Jun 30, 2024 | 2.52 Mn |
| Mar 31, 2024 | -54,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | -16,000.00 |
| Jun 30, 2023 | -140,000.00 |
| Mar 31, 2023 | -49,000.00 |
| Dec 31, 2022 | 106,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | -165,000.00 |
| Mar 31, 2022 | 443,000.00 |
| Dec 31, 2021 | 70.18 Mn |
| Sep 30, 2021 | 170,579.00 |
| Jun 30, 2021 | 2,185.00 |